TFF Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 12, 2024	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Market Cap	480	396	519	1,061	1,027	736
Market Cap Growth	-28.13%	-23.73%	-51.07%	3.39%	39.50%	1.37%
Enterprise Value	884.9	396.05	914.74	1,392	1,260	914.14
PE Ratio	13.78	39.25	14.72	16.42	16.93	17.94
Forward PE	27.76	14.65	11.86	14.48	15.72	21.80
PEG Ratio	-	1.41	1.41	1.41	1.01	1.62
PS Ratio	0.99	1.10	1.06	1.90	2.04	2.12
PB Ratio	0.82	-	0.93	1.89	2.02	1.57
P/TBV Ratio	-	-	1.23	2.46	2.65	2.13
P/FCF Ratio	-	-	-	-	-	35.70
P/OCF Ratio	42.73	-	45.74	261.59	-	21.44
EV/Sales Ratio	1.77	1.10	1.88	2.49	2.50	2.63
EV/EBITDA Ratio	9.45	1.10	9.91	11.36	11.80	15.97
EV/EBIT Ratio	12.35	1.10	13.42	13.25	13.90	20.92
EV/FCF Ratio	-	-	-	-	-	44.35
Debt / Equity Ratio	-	-	0.28	0.22	0.10	0.19
Debt / EBITDA Ratio	-	-	4.89	3.37	3.08	4.70
Debt / FCF Ratio	-	-	-	-	-	13.04
Net Debt / Equity Ratio	-	-	0.64	0.54	0.42	0.34
Net Debt / EBITDA Ratio	-	-	3.90	2.50	1.98	2.74
Net Debt / FCF Ratio	-	-	-17.91	-4.78	-6.31	7.61
Asset Turnover	0.64	0.63	0.43	0.54	0.56	0.43
Inventory Turnover	0.34	0	0.42	0.59	0.69	0.57
Quick Ratio	-	-	0.60	0.64	0.67	0.84
Current Ratio	-	-	2.06	1.90	1.74	2.11
Return on Equity (ROE)	6.21%	115.30%	6.18%	12.00%	12.23%	9.15%
Return on Assets (ROA)	4.22%	62.03%	4.39%	6.80%	7.52%	3.94%
Return on Invested Capital (ROIC)	-	-	5.35%	8.66%	9.82%	5.11%
Return on Capital Employed (ROCE)	7.41%	91.37%	8.98%	15.80%	15.25%	7.73%
Earnings Yield	7.26%	2.55%	6.79%	6.09%	5.91%	5.57%
FCF Yield	-	0.00%	-	-	-	2.80%
Dividend Yield	923.08%	0.00%	3.03%	1.43%	0.99%	1.19%
Payout Ratio	42.36%	0.00%	44.70%	23.51%	16.75%	21.29%
Buyback Yield / Dilution	0.03%	0.00%	0.03%	0.00%	0.27%	0.23%
Total Shareholder Return	923.11%	0.00%	3.06%	1.44%	1.25%	1.42%

SEC Filings: 10-K · 10-Q